9 Meters Biopharma, Inc. MNTRQ

Market cap
$1.0M
P/E
0.0×
Mar '23 Dec '22 Sep '22 Jun '22 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Quick Ratio
0.49 0.97 1.23 3.15
Current Ratio
0.59 1.08 1.43 3.36
Net Debt/EBITDA
0.20 1.06 (0.32) 2.62
Debt/Assets
55.51% 59.52% 43.79% 0.45%
Debt/Equity
(0.82) 8.22 1.37 0.01
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.70 0.82 1.07 0.70
Capex/Depreciation
0.00 0.00 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Yield
— — — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.72) (0.75) (0.77) (0.60)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.72) (0.75) (0.77) (0.60)
Cash per Share
0.56 2.29 1.22 2.27
Shareholders Equity per Share
(0.46) 0.19 1.04 1.71
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(0.46) 0.19 1.04 1.71
Free Cash Flow
(9.75) (9.74) (9.97) (7.79)
Working Capital
(6.38) 2.32 5.59 22.01
Capital Expenditures
— 0.00 0.00 0.00
Net Current Asset Value
(6.41) 2.27 (10.22) 21.93
EV/EBIT
— — — —
Capex to Sales
— 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%
Other line items
Average Payables
3.07 3.74 1.38 1.98
Average Assets
24.29 41.66 49.41 48.75
Average Common Equity
12.32 22.00 31.37 40.61

Fold the line items

Columns are period end dates